FDA accepts AstraZeneca's marketing application for expanded use of cancer med Lynparza View More $AZN
Renewable energy has little impact on bottom line so far, BP's Dudley says View More $BP

Subscribe to Email Notifications

Stay up to date with our latest articles

Oppenheimer pricing boost for Grainger next year View More $GWW
Synopsys acquires OTP NVM provider View More $SNPS